Literature DB >> 9699820

Gentamicin release from old cement during revision hip arthroplasty.

J W Powles1, R F Spencer, A M Lovering.   

Abstract

Bone cement containing gentamicin may release antibiotic when fractured during revision operations. Tissue samples taken during surgery may be contaminated by gentamicin and give inaccurate microbiological assessment. We studied five patients in whom cement containing gentamicin had been used in the primary procedure. During revision hip replacement, samples of joint fluid, tissues and cement were taken both before and after disruption of the cement. With the exception of one sample of joint fluid, low concentrations of gentamicin were recorded in the samples taken before the cement was disrupted, but after disruption the specimens contained gentamicin at concentrations high enough to inhibit or prevent growth of sensitive organisms. The cement contained very high levels up to ten years after insertion. Our findings suggest that no reliance can be placed on the microbiological assessment of specimens taken once cement splitting has started and that specimens should therefore be taken as early as possible.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699820

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  11 in total

1.  Prosthetic Joint Infection.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

2.  A preliminary study of the release of quaternary ammonium antimicrobial compounds from acrylic bone cement.

Authors:  Manojgna Mathey; Vijaya Surana; Mark Edwards; John W Nicholson
Journal:  J Mater Sci Mater Med       Date:  2009-03-04       Impact factor: 3.896

Review 3.  Antibiotic-loaded Bone Cement as Prophylaxis in Total Joint Replacement.

Authors:  Javier Martínez-Moreno; Virginia Merino; Amparo Nácher; José Luis Rodrigo; Mónica Climente; Matilde Merino-Sanjuán
Journal:  Orthop Surg       Date:  2017-11       Impact factor: 2.071

Review 4.  Use of antibiotic-loaded cement in total knee arthroplasty.

Authors:  Pedro Hinarejos; Pau Guirro; Lluis Puig-Verdie; Raul Torres-Claramunt; Joan Leal-Blanquet; Juan Sanchez-Soler; Joan Carles Monllau
Journal:  World J Orthop       Date:  2015-12-18

5.  Direct detection of Staphylococcus osteoarticular infections by use of Xpert MRSA/SA SSTI real-time PCR.

Authors:  Anne Dubouix-Bourandy; Aymard de Ladoucette; Valerie Pietri; Nazim Mehdi; David Benzaquen; Régis Guinand; Jean-Marc Gandois
Journal:  J Clin Microbiol       Date:  2011-10-12       Impact factor: 5.948

6.  Prophylaxis and treatment of infection in long bones using an antibiotic-loaded ceramic coating with interlocking intramedullary nails.

Authors:  Emilie-Ann Downey; Kayla M Jaime; Taylor J Reif; Asim M Makhdom; S Robert Rozbruch; Austin T Fragomen
Journal:  J Bone Jt Infect       Date:  2022-04-22

7.  Effect of pulsed ultrasound in combination with gentamicin on bacterial viability in biofilms on bone cements in vivo.

Authors:  G T Ensing; B L Roeder; J L Nelson; J R van Horn; H C van der Mei; H J Busscher; W G Pitt
Journal:  J Appl Microbiol       Date:  2005       Impact factor: 3.772

8.  Elution and Mechanical Strength of Vancomycin-Loaded Bone Cement: In Vitro Study of the Influence of Brand Combination.

Authors:  Sheng-Hsun Lee; Ching-Lung Tai; Szu-Yuan Chen; Chih-Hsiang Chang; Yu-Han Chang; Pang-Hsin Hsieh
Journal:  PLoS One       Date:  2016-11-17       Impact factor: 3.240

Review 9.  Antibiotic-loaded cement in orthopedic surgery: a review.

Authors:  Alessandro Bistolfi; Giuseppe Massazza; Enrica Verné; Alessandro Massè; Davide Deledda; Sara Ferraris; Marta Miola; Fabrizio Galetto; Maurizio Crova
Journal:  ISRN Orthop       Date:  2011-08-07

10.  Elution kinetics of vancomycin and gentamicin from carriers and their effects on mesenchymal stem cell proliferation: an in vitro study.

Authors:  Tomas Kucera; Lenka Ryskova; Tomas Soukup; Jana Malakova; Eva Cermakova; Pavel Mericka; Jakub Suchanek; Pavel Sponer
Journal:  BMC Musculoskelet Disord       Date:  2017-09-02       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.